DE vs MRK: Which Is the Better Buy?

Side-by-side comparison of Deere & Company and Merck & Co., Inc. β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-05-04.
Deere & Company Β· Industrials
$578.39
+22.4% upside to fair value
Grade C
VS
Merck & Co., Inc. Β· Healthcare
$119.07
-4.0% upside to fair value
Grade D High Quality
QuantHub Verdict
DE has more upside to fair value (+22.4%). MRK trades at a lower forward P/E (16.2x). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric DE MRK
Current Price $578.39 $119.07
Fair Value Estimate $708.19 $114.30
Upside to Fair Value +22.4% -4.0%
Market Cap $156.2B $294.4B
Forward P/E 32.5x 16.2x
EV / EBITDA 18.4x 12.6x
Price / Sales 3.4x 4.5x
Price / FCF 43.7x 23.8x
Revenue Growth YoY +16.3% +5.0%
Gross Margin 35.6% 81.5%
Operating Margin 18.5% 41.2%
Return on Equity 18.9% 36.2%
Dividend Yield 0% 0%
FCF Yield 2.29% 4.2%
Analyst Consensus Buy Hold
Investment Thesis
DE β€” Deere & Company
Deere & Company is a leading manufacturer of agricultural, construction, and forestry machinery, with a strong position in production and precision agriculture, small agriculture and turf, and construction and forestry segments. The company benefits from a durable competitive moat driven by its brand, intangible assets, and switching costs, supported by a CEO with deep institutional knowledge and…
MRK β€” Merck & Co., Inc.
Merck & Co., Inc. is a leading global healthcare company specializing in pharmaceuticals, particularly oncology and vaccines. The company benefits from a strong business quality characterized by a durable competitive moat, high gross margins of 81.5%, and a robust return on equity of 36.2%. Despite these strengths, the stock is currently fairly valued but slightly overvalued by 4% relative to its…
Accumulation Zones
Metric DE MRK
Zone Low $531.14 $85.72
Zone High $601.96 $97.16
In Buy Zone? Yes No
← DE Research    MRK Research β†’    All Research